Weight loss for better type 2 diabetes outcomes – Your questions answered

Expert/s: Dr Gary Deed
   Rated 0 / 5 stars

Claim CPD for this activity

Educational Activities (EA)
30 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)
30 minutes

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)
0 minutes

These are activities that use your work data to ensure quality results.

EA
30 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
30 minutes

These are activities that require reflection on feedback about your work.

MO
0 minutes

These are activities that use your work data to ensure quality results.

Listen to the episode

Description

The questions answered in this podcast are listed below. They were compiled by GPs and health professionals around Australia.

  1. Can you address the issue of why GLP1’s particularly good for in patients with type 2 diabetes?
  2. How best to use the GLP1 or the incretins versus the SGLT2 inhibitors.
  3. Is SGLT2’s the way to go?
  4. Let’s say you have started the patient on a GLP1 injectable. The questions and concerns that come up are: what about pancreatitis, GI side effects, what stops the compliance and how you might deal with these?
  5. Would you suggest blood tests for the pancreatitis? Or would you also add some sort of imaging to that?
  6. Tips on how to reduce the GI adverse effects.
  7. What are your comments on GLPs and mental health, use with SSRIs and suicidal ideation.
  8. Would it be fair to say that in obese patients with type 2 diabetes who have a strong history of depression, that if we had to make them help them lose weight, the GLP1s may be the way to go versus bariatric surgery, which has a significant mental health consequence.
  9. Do you have an idea how much weight can be lost with twincretin?
  10. How real is cardiovascular risk with Duromine?
  11. Is insulin the best treatment for skinny diabetics?
  12. Would you still recommend apart from the C-peptide, antibodies and islet cells, or different types of antibodies?
  13. What are the behavioural strategies in helping patients lose weight?
  14. What is bowel obstruction associated with GLP1s?

 

Guest: Dr Gary Deed, General Pratitioner

Host: Dr David Lim, GP and Medical Educator

Total time: 31 mins

Last Updated: 7 Nov, 2023

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Further your CPD learning

Based on this educational activity, complete these learning modules to gain additional CPD.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Expert panel - A/Prof Samantha Hocking, Prof John Dixon, facilitated by A/Prof Ralph Audehm

Expert panel - A/Prof Samantha Hocking, Prof John Dixon, facilitated by A/Prof Ralph Audehm

GLP-1 Prescribing Expert Panel Discussion

Prof Rukshen Weerasooriya

Prof Rukshen Weerasooriya

Arrhythmia Management in Primary Care

Dr Rupert Hinds

Dr Rupert Hinds

Infant Allergy Cases

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Gary Deed

expert

Dr Gary Deed

General Practitioner; Coorparoo, QLD; National Chair, RACGP Diabetes Specific Interest Group

Recent articles

Find your area of interest

Share this

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.